Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; ...
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.
The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life.
Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...
Live Science on MSN
An experimental mRNA treatment counters immune cell aging in mice
A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds.
Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback